Omicron subvariant BA.5 can cause more severe disease

FHS
July 17, 2023
12:36 pm

Omicron-derived virus variants are currently responsible for most SARS-CoV-2 infections worldwide. Compared to earlier virus variants, Omicron rarely causes severe disease.

Progress in battle against stomach cancer

Researchers at Ludwig-Maximilians-Universität München (LMU) in Germany have discovered a weakness in the bacterium Helicobacter pylori, which could be exploited to develop new drugs.H. pylori,

April 26, 2023

Ultra-processed foods linked to higher glaucoma risk, study warns

Study finds a significant relationship between the highest intake of ultra-processed foods, especially sweets, and an increased risk of developing glaucoma among Spanish university graduates,

April 8, 2024

Another Eylea competitor prepares to enter the ring following positive PhIII readout

Regeneron may soon be staring down another competitor to its blockbuster Eylea. Sandoz’s biosimilar candidate aflibercept proved equivalent to the brand-name eye drug in a

August 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.